Withdrawal Notice: Novel Homeodomain Transcription Factor Nkx2.2 in the Brain Tumor Development

(E-pub Ahead of Print)

Author(s): Mubeena PM Mariyath, Mehdi Hayat Shahi*, Shirin Farheen, Mohd Tayyab, Nabeela Khanam, Asif Ali.

Journal Name: Current Cancer Drug Targets

Become EABM
Become Reviewer

Abstract:

The article has been withdrawn at the request of the editor of the journal Current Cancer Drug Targets

Bentham Science apologizes to the readers of the journal for any inconvenience this may cause.

Bentham Science Disclaimer:

It is a condition of publication that manuscripts submitted to this journal have not been published and will not be simultaneously submitted or published elsewhere. Furthermore, any data, illustration, structure or table that has been published elsewhere must be reported, and copyright permission for reproduction must be obtained. Plagiarism is strictly forbidden, and by submitting the article for publication the authors agree that the publishers have the legal right to take appropriate action against the authors, if plagiarism or fabricated information is discovered. By submitting a manuscript, the authors agree that the copyright of their article is transferred to the publishers if and when the article is accepted for publication.

Rights & PermissionsPrintExport Cite as

Article Details

(E-pub Ahead of Print)
DOI: 10.2174/1568009618666180102111539

Article Metrics

PDF: 12

Special-new-year-discount